Education
About Us
Working with TipRanks
Follow Us
Shield Therapeutics PLC (GB:STX)
LSE:STX
STX Analyst Ratings
Hold
0 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
STX Stock 12 Month Forecast
Average Price Target
6.50p
▼(-7.14% Downside)
| Highest Price Target6.50p | Average Price Target6.50p | Lowest Price Target6.50p |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TR | OpenAI - 4o
5.5p→6.5p
Hold
-7.14%
Downside
Reiterated
08/19/25
Stifel Nicolaus
3.5p→3.8p
Hold
-45.71%
Downside
Reiterated
02/19/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TR | OpenAI - 4o
5.5p→6.5p
Hold
-7.14%
Downside
Reiterated
08/19/25
Stifel Nicolaus
3.5p→3.8p
Hold
-45.71%
Downside
Reiterated
02/19/25
STX Analyst Recommendation Trends
Rating
Feb 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
4
5
7
9
9
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
5
7
9
9
Each month's total comprises the sum of three months' worth of ratings.
STX Financial Forecast
STX Stock Forecast FAQ
What is GB:STX’s average 12-month price target, according to analysts?
Based on analyst ratings, Shield Therapeutics PLC’s 12-month average price target is 6.50.
What is GB:STX’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for GB:STX, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Shield Therapeutics PLC a Buy, Sell or Hold?
Shield Therapeutics PLC has a consensus rating of Hold, which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
What is Shield Therapeutics PLC’s share price target?
The average share price target for Shield Therapeutics PLC is 6.50. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is 6.50p ,and the lowest forecast is 6.50p. The average share price target represents -7.14% Decrease from the current price of 7p.
The highest analyst share price target is 6.50p ,and the lowest forecast is 6.50p. The average share price target represents -7.14% Decrease from the current price of 7p.
What do analysts say about Shield Therapeutics PLC?
Shield Therapeutics PLC’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of Shield Therapeutics PLC?
To buy shares of GB:STX, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.